Grant MB - Search Results

1

Cell-based therapies for diabetic retinopathy.

Shaw LC, Neu MB, Grant MB. Shaw LC, et al. Among authors: grant mb. Curr Diab Rep. 2011 Aug;11(4):265-74. doi: 10.1007/s11892-011-0197-8. Curr Diab Rep. 2011. PMID: 21611766 Free PMC article. Review.

2

Fibronectin fragments modulate human retinal capillary cell proliferation and migration.

Grant MB, Caballero S, Bush DM, Spoerri PE. Grant MB, et al. Diabetes. 1998 Aug;47(8):1335-40. doi: 10.2337/diab.47.8.1335. Diabetes. 1998. PMID: 9703336

3

The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study.

Grant MB, Mames RN, Fitzgerald C, Hazariwala KM, Cooper-DeHoff R, Caballero S, Estes KS. Grant MB, et al. Diabetes Care. 2000 Apr;23(4):504-9. doi: 10.2337/diacare.23.4.504. Diabetes Care. 2000. PMID: 10857943 Clinical Trial.

4

The therapeutic problem of proliferative diabetic retinopathy: targeting somatostatin receptors.

Davis MI, Wilson SH, Grant MB. Davis MI, et al. Among authors: grant mb. Horm Metab Res. 2001 May;33(5):295-9. doi: 10.1055/s-2001-15286. Horm Metab Res. 2001. PMID: 11440276 Review.

5

Modulation of retinal endothelial cell behaviour by insulin-like growth factor I and somatostatin analogues: implications for diabetic retinopathy.

Wilson SH, Davis MI, Caballero S, Grant MB. Wilson SH, et al. Among authors: grant mb. Growth Horm IGF Res. 2001 Jun;11 Suppl A:S53-9. doi: 10.1016/s1096-6374(01)80009-5. Growth Horm IGF Res. 2001. PMID: 11527089

6

Development of hammerhead ribozymes to modulate endogenous gene expression for functional studies.

Fritz JJ, Lewin A, Hauswirth W, Agarwal A, Grant M, Shaw L. Fritz JJ, et al. Methods. 2002 Oct;28(2):276-85. doi: 10.1016/s1046-2023(02)00233-5. Methods. 2002. PMID: 12413427

7

Expression of IGFBP-3 by human retinal endothelial cell cultures: IGFBP-3 involvement in growth inhibition and apoptosis.

Spoerri PE, Caballero S, Wilson SH, Shaw LC, Grant MB. Spoerri PE, et al. Among authors: grant mb. Invest Ophthalmol Vis Sci. 2003 Jan;44(1):365-9. doi: 10.1167/iovs.02-0309. Invest Ophthalmol Vis Sci. 2003. PMID: 12506097

8

Somatostatin analogues as drug therapies for retinopathies.

Grant MB, Caballero S. Grant MB, et al. Drugs Today (Barc). 2002 Nov;38(11):783-91. doi: 10.1358/dot.2002.38.11.820138. Drugs Today (Barc). 2002. PMID: 12582462 Review.

9

Fibronectin fragments promote human retinal endothelial cell adhesion and proliferation and ERK activation through alpha5beta1 integrin and PI 3-kinase.

Wilson SH, Ljubimov AV, Morla AO, Caballero S, Shaw LC, Spoerri PE, Tarnuzzer RW, Grant MB. Wilson SH, et al. Among authors: grant mb. Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1704-15. doi: 10.1167/iovs.02-0773. Invest Ophthalmol Vis Sci. 2003. PMID: 12657612

10

Reduction in preretinal neovascularization by ribozymes that cleave the A2B adenosine receptor mRNA.

Afzal A, Shaw LC, Caballero S, Spoerri PE, Lewin AS, Zeng D, Belardinelli L, Grant MB. Afzal A, et al. Among authors: grant mb. Circ Res. 2003 Sep 19;93(6):500-6. doi: 10.1161/01.RES.0000091260.78959.BC. Epub 2003 Aug 14. Circ Res. 2003. PMID: 12919950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters